K.s. Atlas DIS Tic.ltd STI Pharmaceutical Import Profile — Turkey (DGFT 2022–2026)

Name: K.s. Atlas DIS Tic.ltd STI Pharmaceutical Import Records from India — 4 Products, $7.6K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

K.s. Atlas DIS Tic.ltd STI — Pharmaceutical Importer Profile (2026) | 4 Products, $7.6K Trade | TransData Nexus

K.s. Atlas DIS Tic.ltd STI

Pharmaceutical Importer · Turkey · Advanced Oncology Focus · $7.6K Total Trade · DGFT Verified

K.s. Atlas DIS Tic.ltd STI is a pharmaceutical importer based in Turkey with a total trade value of $7.6K across 4 products in 2 therapeutic categories. Based on 12 verified import shipments from Indian Customs (DGFT) records, K.s. Atlas DIS Tic.ltd STI is the #1 buyer in 1 product including Levodopa Carbidopa. K.s. Atlas DIS Tic.ltd STI sources from 1 verified Indian supplier, with Rizlife Healthcare accounting for 100.0% of imports.

K.s. Atlas DIS Tic.ltd STI — Import Portfolio & Supplier Network

K.s. Atlas DIS Tic.ltd STI import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to K.s. Atlas DIS Tic.ltd STI?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Rizlife Healthcare	$377.1K	318	100.0%

K.s. Atlas DIS Tic.ltd STI sources from 1 verified Indian supplier across 106 distinct formulations. The sourcing is highly concentrated — Rizlife Healthcare accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does K.s. Atlas DIS Tic.ltd STI Import?

Formulation	Value	Ships
Cytomid-250( flutamide TAB IP)bt	$17.5K	3
Entavir 1 MG(entecavir TAB IP 1 MG)bt	$14.5K	3
Rybelsus 14 MG(semaglutide TAB)bt	$13.2K	3
Budez cr(budesonide controlled release	$13.0K	3
Penicitin 250 MG(penicillamine CAPS	$12.3K	3
Nimotime-30( nimodipine TAB IP 30 MG)	$11.3K	3
Cernos gel(testosterone gel)bt	$10.9K	3
Ryfxacare-400(rifaximin tab400 MG)	$10.3K	3
Floricot 100 MCG(fludrocortisone tan	$8.7K	3
Mitomycin 40(mitomycin injection IP 40	$8.4K	3
Viraday(efavirenz emtricitabine	$8.3K	3
Methotrex 500(methotrexate injection	$7.1K	3
Zolmist(zolmitriptan nasal spray IP)bt	$6.8K	3
Ddr 60(dexlansoprazole mr capsules 60 MG	$6.7K	3
Velasof(sofosbuvir 400 MG velpatasvir	$6.1K	3

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Cladribine	Advanced Oncology	$3.6K	3	1.6%	7
2	Mitoxantrone	Advanced Oncology	$1.6K	3	0.1%	8
3	Axitinib	Advanced Oncology	$1.2K	3	1.3%	9
4	Levodopa Carbidopa	Combination Drugs	$1.1K	3	15.2%	1

K.s. Atlas DIS Tic.ltd STI imports 4 pharmaceutical products across 2 categories into Turkey totaling $7.6K. The company is the #1 buyer for 1 product: Levodopa Carbidopa.

K.s. Atlas DIS Tic.ltd STI — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

K.s. Atlas Dis Ticaret Ltd. Sti., established on February 18, 1998, is a Turkish company headquartered in Mersin, operating primarily in the freight transportation arrangement industry. While its main focus is on logistics and transportation, the company has diversified its operations to include the importation of pharmaceutical products. This strategic expansion allows K.s. Atlas Dis Ticaret Ltd. Sti. to serve as a pharmaceutical buyer and importer within Turkey's healthcare sector.

The company's role in Turkey's pharmaceutical distribution network involves sourcing and importing finished pharmaceutical formulations from international suppliers, particularly from India. By leveraging its logistics expertise, K.s. Atlas Dis Ticaret Ltd. Sti. ensures the efficient delivery of these products to various stakeholders in the Turkish healthcare system, including hospitals, pharmacies, and clinics. This integration of logistics and pharmaceutical importation positions the company as a key player in facilitating the availability of essential medications across Turkey.

2Distribution Network

K.s. Atlas Dis Ticaret Ltd. Sti. operates a distribution network centered in Mersin, a strategic port city in southern Turkey. This location provides the company with direct access to international shipping routes, facilitating the importation of pharmaceutical products from suppliers, notably from India. The company's logistics capabilities are enhanced by its established infrastructure, enabling efficient warehousing, inventory management, and distribution processes. While specific details about additional warehouse locations and geographic coverage within Turkey are not publicly disclosed, the Mersin facility serves as a critical hub for the company's operations.

3Industry Role

In Turkey's pharmaceutical supply chain, K.s. Atlas Dis Ticaret Ltd. Sti. functions as a pharmaceutical importer and distributor. By sourcing finished pharmaceutical formulations from international suppliers, particularly from India, the company plays a pivotal role in ensuring the availability of a diverse range of medications in the Turkish market. Its operations bridge the gap between foreign manufacturers and local healthcare providers, contributing to the overall efficiency and effectiveness of Turkey's pharmaceutical distribution network.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — K.s. Atlas DIS Tic.ltd STI

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

K.s. Atlas Dis Ticaret Ltd. Sti. demonstrates a high level of supplier concentration, sourcing all its pharmaceutical imports from a single supplier, RIZLIFE HEALTHCARE. This exclusive sourcing strategy indicates a strong, possibly strategic, partnership between the two entities. The company's total import value from India amounts to $8,000 USD, distributed across 12 shipments and encompassing 106 unique formulations. The top five imported products include Cladribine, Mitoxantrone, Axitinib, and Levodopa Carbidopa, with Levodopa Carbidopa being the most significant, accounting for 15.2% of the total import value.

The reliance on a single supplier can present risks, such as potential supply chain disruptions or dependency on the supplier's stability. However, the extensive range of unique formulations and the significant volume of imports suggest a well-established and stable relationship between K.s. Atlas Dis Ticaret Ltd. Sti. and RIZLIFE HEALTHCARE. This partnership likely offers mutual benefits, including favorable terms, consistent product quality, and reliable supply, which are crucial for maintaining the company's position in the Turkish pharmaceutical market.

2Supply Chain Resilience

K.s. Atlas Dis Ticaret Ltd. Sti.'s supply chain resilience is closely tied to its exclusive partnership with RIZLIFE HEALTHCARE. The company's importation of 106 unique pharmaceutical formulations from a single supplier indicates a deep integration and reliance on this supplier for product diversity and availability. While this concentrated sourcing strategy can lead to operational efficiencies and strong supplier relationships, it also exposes the company to risks associated with supplier dependency.

Importing Pharmaceuticals into Turkey — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Turkey

1Regulatory Authority & Framework

The Turkish Medicines and Medical Devices Agency (TİTCK) is the primary regulatory authority overseeing the pharmaceutical sector in Turkey. Operating under the Ministry of Health, TİTCK is responsible for ensuring the safety, efficacy, and quality of medicinal products and medical devices available in the Turkish market. The agency enforces regulations that govern the importation, marketing, and distribution of pharmaceutical products, aligning with international standards to protect public health.

Key legislation governing pharmaceutical imports into Turkey includes the Licensing Regulation on Human Medicinal Products, which outlines the procedures and requirements for obtaining marketing authorization for pharmaceutical products. This regulation specifies the necessary documentation, quality standards, and compliance measures that importers and manufacturers must adhere to when introducing new medicinal products into the Turkish market.

2Import Licensing & GMP

Import licensing in Turkey is a critical process regulated by TİTCK. Pharmaceutical products cannot be marketed or distributed within Turkey without obtaining a valid marketing authorization from the agency. This authorization ensures that imported medicinal products meet the required safety, efficacy, and quality standards. The process involves submitting comprehensive documentation, including clinical data, manufacturing details, and compliance with Good Manufacturing Practice (GMP) standards.

K.s. Atlas DIS Tic.ltd STI — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

K.s. Atlas Dis Ticaret Ltd. Sti.'s product strategy focuses on importing pharmaceutical formulations that address critical therapeutic areas, particularly in oncology and combination therapies. The company's top five imported products include Cladribine, Mitoxantrone, Axitinib, and Levodopa

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — K.s. Atlas DIS Tic.ltd STI

What products does K.s. Atlas DIS Tic.ltd STI import from India?

K.s. Atlas DIS Tic.ltd STI imports 4 pharmaceutical products across 2 categories. Top imports: Cladribine ($3.6K), Mitoxantrone ($1.6K), Axitinib ($1.2K), Levodopa Carbidopa ($1.1K).

Who supplies pharmaceuticals to K.s. Atlas DIS Tic.ltd STI from India?

K.s. Atlas DIS Tic.ltd STI sources from 1 verified Indian suppliers. The primary supplier is Rizlife Healthcare (100.0% of imports, $377.1K).

What is K.s. Atlas DIS Tic.ltd STI's total pharmaceutical import value?

K.s. Atlas DIS Tic.ltd STI's total pharmaceutical import value from India is $7.6K, based on 12 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does K.s. Atlas DIS Tic.ltd STI focus on?

K.s. Atlas DIS Tic.ltd STI imports across 2 categories. The largest: Advanced Oncology (85.1%), Combination Drugs (14.9%).

Get Full K.s. Atlas DIS Tic.ltd STI Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.